New Delhi: “Affordability and reimbursement are challenges not just in India but globally,” said Feng Dong , Vice President, Asia Region-Led Markets, EurAsia, Medtronic , underscoring the urgent need to expand access to advanced diabetes care.

In an exclusive interaction with ETHealthworld’s Prathiba Raju, Dong revealed that his daughter, a type 1 diabetes patient, relies on a insulin pump while pursuing her PhD , a testament, he said, to how technology can enable patients to live full, productive lives.

“We want every Indian patient to have that opportunity,” Feng added, noting that progress is already underway as several states introduce reimbursement schemes, steadily increasing access to insulin pump therapy.

Adding to this, he informed that although an estimated 900,000 i

See Full Page